Home › Kidney Stones › Illinois › Chicago
Kidney Stones clinical trials in Chicago, IL
7 studies for Kidney Stones are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
RecruitingPhase 2Healthy volunteers welcome
- The University of Chicago Medical Center, Chicago
SGLT2i in Kidney Stones
RecruitingEarly phase 1Mentions payment for participants
- University of Chicago, Chicago
Kidney Stone Inflammation
RecruitingObservational studyHealthy volunteers welcome
- University of Chicago Medical Center, Chicago
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
Recruiting
- University of Chicago Medical Center, Chicago
Oxalate and Citrate
RecruitingHealthy volunteers welcome
- University of Chicago Medical Center, Chicago
Oxalate and Citrate in Humans - Response to Citrate
RecruitingHealthy volunteers welcome
- University of Chicago Medical Center, Chicago
GI Oxalate Absorption
Recruiting
- University of Chicago Medical Center, Chicago
About Kidney Stones
Kidney stones (or nephrolithiasis) symptoms include vomiting, blood in your urine and more. Find a full list of symptoms and treatments available
More about Kidney Stones on MedlinePlus
Kidney Stones trials in other cities
- Birmingham, AL7 studies
- New York City, NY6 studies
- Dallas, TX4 studies
- Kansas City, KS4 studies
- Miami, FL3 studies
- Philadelphia, PA3 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.